Publication | Closed Access

Comparison of PET/CT imaging with [18F]FDOPA and cholecystokinin-2 receptor targeting [68Ga]Ga-DOTA-MGS5 in a patient with advanced medullary thyroid carcinoma

Positron Emission TomographyEngineeringOncologic ImagingMedical ImagingImaging AgentPet-mriMolecular ImagingCholecystokinin-2 ReceptorOncologyRadiation OncologyNuclear MedicineRadiologyHealth Sciences